Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease.

Wright JW, Harding JW.

J Alzheimers Dis. 2019;67(2):469-480. doi: 10.3233/JAD-181035.

PMID:
30664507
2.

Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine.

Church KJ, Vanderwerff BR, Riggers RR, Mateo-Victoriano B, Fagnan M, Harris PH, LeValley JC, Harding JW.

Anticancer Drugs. 2018 Apr;29(4):295-306. doi: 10.1097/CAD.0000000000000598.

PMID:
29389804
3.

Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells.

Church KJ, Vanderwerff BR, Riggers RR, McMicheal MD, Mateo-Victoriano B, Sukumar SR, Harding JW.

Anticancer Drugs. 2016 Sep;27(8):766-79. doi: 10.1097/CAD.0000000000000390.

4.

Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure.

Uribe PM, Kawas LH, Harding JW, Coffin AB.

Front Cell Neurosci. 2015 Jan 28;9:3. doi: 10.3389/fncel.2015.00003. eCollection 2015.

5.

The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.

Wright JW, Harding JW.

J Alzheimers Dis. 2015;45(4):985-1000. doi: 10.3233/JAD-142814. Review.

PMID:
25649658
6.

The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.

Wright JW, Kawas LH, Harding JW.

Prog Neurobiol. 2015 Feb;125:26-46. doi: 10.1016/j.pneurobio.2014.11.004. Epub 2014 Nov 29. Review.

PMID:
25455861
7.

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.

Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, Harding JW.

J Pharmacol Exp Ther. 2014 Nov;351(2):390-402. doi: 10.1124/jpet.114.218735. Epub 2014 Sep 3.

8.

A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.

Wright JW, Kawas LH, Harding JW.

Front Endocrinol (Lausanne). 2013 Oct 25;4:158. doi: 10.3389/fendo.2013.00158. Review.

9.

A role for matrix metalloproteinases in nicotine-induced conditioned place preference and relapse in adolescent female rats.

Natarajan R, Harding JW, Wright JW.

J Exp Neurosci. 2013 Apr 4;7:1-14. doi: 10.4137/JEN.S11381. eCollection 2013.

10.

Importance of the brain Angiotensin system in Parkinson's disease.

Wright JW, Harding JW.

Parkinsons Dis. 2012;2012:860923. doi: 10.1155/2012/860923. Epub 2012 Nov 7.

11.

Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.

McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW.

J Pharmacol Exp Ther. 2013 Jan;344(1):141-54. doi: 10.1124/jpet.112.199497. Epub 2012 Oct 10.

12.

Nanoscale mapping of the Met receptor on hippocampal neurons by AFM and confocal microscopy.

Kawas LH, Benoist CC, Harding JW, Wayman GA, Abu-Lail NI.

Nanomedicine. 2013 Apr;9(3):428-38. doi: 10.1016/j.nano.2012.08.008. Epub 2012 Sep 7.

PMID:
22960190
13.

Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension.

Wright JW, Mizutani S, Harding JW.

Int J Hypertens. 2012;2012:124758. doi: 10.1155/2012/124758. Epub 2012 Jun 26.

14.

The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Wright JW, Harding JW.

Pflugers Arch. 2013 Jan;465(1):133-51. doi: 10.1007/s00424-012-1102-2. Epub 2012 Apr 26. Review.

PMID:
22535332
15.

The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in Rats.

Wright JW, Wilson WL, Wakeling V, Boydstun AS, Jensen A, Kawas L, Harding JW.

Brain Sci. 2012 Aug 20;2(3):298-318. doi: 10.3390/brainsci2030298.

16.

Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers.

Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, Harding JW.

J Pharmacol Exp Ther. 2012 Mar;340(3):539-48. doi: 10.1124/jpet.111.188136. Epub 2011 Nov 30.

PMID:
22129598
17.

A Preliminary Evaluation of Functional Communication Training Effectiveness and Language Preference When Spanish and English are Manipulated.

Padilla Dalmau YC, Wacker DP, Harding JW, Berg WK, Schieltz KM, Lee JF, Breznican GP, Kramer AR.

J Behav Educ. 2011 Dec;20(4):233-251.

18.

An evaluation of persistence of treatment effects during long-term treatment of destructive behavior.

Wacker DP, Harding JW, Berg WK, Lee JF, Schieltz KM, Padilla YC, Nevin JA, Shahan TA.

J Exp Anal Behav. 2011 Sep;96(2):261-82. doi: 10.1901/jeab.2011.96-261.

19.

Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity.

Kawas LH, Yamamoto BJ, Wright JW, Harding JW.

J Pharmacol Exp Ther. 2011 Nov;339(2):509-18. doi: 10.1124/jpet.111.185694. Epub 2011 Aug 22. Erratum in: J Pharmacol Exp Ther. 2014 Dec;351(3):685.

PMID:
21859930
20.

Brain renin-angiotensin--a new look at an old system.

Wright JW, Harding JW.

Prog Neurobiol. 2011 Sep 15;95(1):49-67. doi: 10.1016/j.pneurobio.2011.07.001. Epub 2011 Jul 13. Review.

PMID:
21777652
21.

Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs.

Benoist CC, Wright JW, Zhu M, Appleyard SM, Wayman GA, Harding JW.

J Pharmacol Exp Ther. 2011 Oct;339(1):35-44. doi: 10.1124/jpet.111.182220. Epub 2011 Jun 30.

22.

Nicotine-induced conditioned place preference in adolescent rats.

Natarajan R, Wright JW, Harding JW.

Pharmacol Biochem Behav. 2011 Sep;99(3):519-23. doi: 10.1016/j.pbb.2011.05.004. Epub 2011 May 11.

PMID:
21600911
23.

Klinefelter's syndrome (47,XXY) among men with systemic lupus erythematosus.

Dillon S, Aggarwal R, Harding JW, Li LJ, Weissman MH, Li S, Cavett JW, Sevier ST, Ojwang JW, D'Souza A, Harley JB, Scofield RH.

Acta Paediatr. 2011 Jun;100(6):819-23. doi: 10.1111/j.1651-2227.2011.02185.x. Epub 2011 Mar 7.

PMID:
21375582
24.

Indirect Effects of Functional Communication Training on Non-Targeted Disruptive Behavior.

Schieltz KM, Wacker DP, Harding JW, Berg WK, Lee JF, Dalmau YC, Mews J, Ibrahimović M.

J Behav Educ. 2011 Mar;20(1):15-32.

25.

Angiotensin II-mediated microvascular thrombosis.

Senchenkova EY, Russell J, Almeida-Paula LD, Harding JW, Granger DN.

Hypertension. 2010 Dec;56(6):1089-95. doi: 10.1161/HYPERTENSIONAHA.110.158220. Epub 2010 Oct 25.

26.

An Evaluation of Manding Across Functions Prior to Functional Communication Training.

Schieltz KM, Wacker DP, Harding JW, Berg WK, Lee JF, Dalmau YC.

J Dev Phys Disabil. 2010 Apr;22(2):131-147.

27.

Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction.

Wright JW, Harding JW.

Neural Plast. 2009;2009:579382. doi: 10.1155/2009/579382. Epub 2010 Feb 10. Review.

28.

The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor.

Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, Harding JW.

J Pharmacol Exp Ther. 2010 Apr;333(1):161-73. doi: 10.1124/jpet.109.161711. Epub 2010 Jan 19. Erratum in: J Pharmacol Exp Ther. 2015 Feb;352(2):379.

29.

The brain RAS and Alzheimer's disease.

Wright JW, Harding JW.

Exp Neurol. 2010 Jun;223(2):326-33. doi: 10.1016/j.expneurol.2009.09.012. Epub 2009 Sep 24. Review.

PMID:
19782074
30.

Habituation-induced neural plasticity in the hippocampus and prefrontal cortex mediated by MMP-3.

Wright JW, Meighan PC, Brown TE, Wiediger RV, Sorg BA, Harding JW.

Behav Brain Res. 2009 Oct 12;203(1):27-34. doi: 10.1016/j.bbr.2009.04.014. Epub 2009 Apr 21.

PMID:
19389428
31.

Conducting Functional Communication Training in Home Settings: A Case Study and Recommendations for Practitioners.

Harding JW, Wacker DP, Berg WK, Lee JF, Dolezal D.

Behav Anal Pract. 2009 Apr 1;2(1):21-33.

32.

The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): effects on spatial memory.

Wilson WL, Munn C, Ross RC, Harding JW, Wright JW.

Brain Res. 2009 May 26;1272:25-31. doi: 10.1016/j.brainres.2009.03.025. Epub 2009 Mar 25.

PMID:
19328191
33.

Analysis of Multiple Manding Topographies during Functional Communication Training.

Harding JW, Wacker DP, Berg WK, Winborn-Kemmerer L, Lee JF, Ibrahimovic M.

Educ Treat Children. 2009 Feb 1;32(1):21-36.

34.

The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.

Wright JW, Harding JW.

J Renin Angiotensin Aldosterone Syst. 2008 Dec;9(4):226-37. doi: 10.1177/1470320308099084. Review.

PMID:
19126664
35.

Evaluation of Mand-Reinforcer Relations Following Long-Term Functional Communication Training.

Wacker DP, Harding JW, Berg WK.

J Speech Lang Pathol Appl Behav Anal. 2008;(2.4-3.1):25-35.

36.

Increase in matrix metalloproteinase-9 levels in the rat medial prefrontal cortex after cocaine reinstatement of conditioned place preference.

Brown TE, Forquer MR, Harding JW, Wright JW, Sorg BA.

Synapse. 2008 Dec;62(12):886-9. doi: 10.1002/syn.20562.

PMID:
18792988
37.

Effects of suprachiasmatic nucleus lesions on habituation of the head-shake response.

Holtfreter KL, Murphy ES, Harding JW, Wright JW.

Neurosci Lett. 2008 Jul 11;439(2):203-7. doi: 10.1016/j.neulet.2008.05.026. Epub 2008 May 14.

PMID:
18524489
38.

Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Wright JW, Yamamoto BJ, Harding JW.

Prog Neurobiol. 2008 Feb;84(2):157-81. Epub 2007 Nov 19. Review.

39.

Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.

Wright JW, Mizutani S, Harding JW.

Heart Fail Rev. 2008 Sep;13(3):367-75. Epub 2007 Nov 7. Review.

PMID:
17987382
40.

Hippocampal MMP-3 elevation is associated with passive avoidance conditioning.

Olson ML, Meighan PC, Brown TE, Asay AL, Benoist CC, Harding JW, Wright JW.

Regul Pept. 2008 Feb 7;146(1-3):19-25. Epub 2007 Jul 19.

PMID:
17698214
41.

Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses.

Meighan PC, Meighan SE, Davis CJ, Wright JW, Harding JW.

J Neurochem. 2007 Sep;102(6):2085-2096. doi: 10.1111/j.1471-4159.2007.04682.x. Epub 2007 Jun 22.

42.

Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory.

Wright JW, Brown TE, Harding JW.

Neural Plast. 2007;2007:73813. Epub 2006 Dec 14.

43.

Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference.

Brown TE, Forquer MR, Cocking DL, Jansen HT, Harding JW, Sorg BA.

Learn Mem. 2007 Mar 9;14(3):214-23. Print 2007 Mar.

44.

Habituation of the head-shake response induces changes in brain matrix metalloproteinases-3 (MMP-3) and -9.

Wright JW, Meighan SE, Murphy ES, Holtfreter KL, Davis CJ, Olson ML, Benoist CC, Muhunthan K, Harding JW.

Behav Brain Res. 2006 Nov 1;174(1):78-85. Epub 2006 Aug 17.

PMID:
16916548
45.

REM sleep deprivation attenuates actin-binding protein cortactin: a link between sleep and hippocampal plasticity.

Davis CJ, Meighan PC, Taishi P, Krueger JM, Harding JW, Wright JW.

Neurosci Lett. 2006 Jun 12;400(3):191-6. Epub 2006 Mar 14.

PMID:
16533564
46.

Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity.

Meighan SE, Meighan PC, Choudhury P, Davis CJ, Olson ML, Zornes PA, Wright JW, Harding JW.

J Neurochem. 2006 Mar;96(5):1227-41. Epub 2006 Feb 8.

47.

AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation.

Davis CJ, Kramár EA, De A, Meighan PC, Simasko SM, Wright JW, Harding JW.

Neuroscience. 2006;137(4):1369-79. Epub 2005 Dec 15.

PMID:
16343778
48.

Roles of brain angiotensins II and III in thirst and sodium appetite.

Wilson WL, Roques BP, Llorens-Cortes C, Speth RC, Harding JW, Wright JW.

Brain Res. 2005 Oct 26;1060(1-2):108-17. Epub 2005 Sep 21.

PMID:
16182260
49.

Role of mitogen-activated protein kinases during recovery from head-shake response habituation in rats.

Murphy ES, Harding JW, Muhunthan K, Holtfreter KL, Wright JW.

Brain Res. 2005 Jul 19;1050(1-2):170-9.

PMID:
15963956
50.

AT4 receptor binding in the developing rabbit.

Burns GA, Ann-Marie T, Jodie H, Harding JW.

Anat Rec A Discov Mol Cell Evol Biol. 2004 Dec;281(2):1276-85.

Supplemental Content

Loading ...
Support Center